tiprankstipranks
Advertisement
Advertisement

GB:AGY Stock Latest News

Allergy Therapeutics Links CFO Incentive Award to Share Price and Growth Targets
Company AnnouncementsAllergy Therapeutics Links CFO Incentive Award to Share Price and Growth Targets
16d ago
Allergy Therapeutics Highlights Positive Allergy Trial Data at EAACI 2026
PremiumCompany Announcements
Allergy Therapeutics Highlights Positive Allergy Trial Data at EAACI 2026
19d ago
Allergy Therapeutics boosts funding as Grassmuno launch and peanut vaccine advance
PremiumCompany Announcements
Allergy Therapeutics boosts funding as Grassmuno launch and peanut vaccine advance
3M ago
Allergy Therapeutics Deepens Real-World Data on Grassmuno® With New GRASS Study
PremiumCompany Announcements
Allergy Therapeutics Deepens Real-World Data on Grassmuno® With New GRASS Study
3M ago
AGY
Allergy Therapeutics Reshapes Major Shareholding Ahead of Potential Hong Kong Listing
PremiumCompany Announcements
Allergy Therapeutics Reshapes Major Shareholding Ahead of Potential Hong Kong Listing
4M ago
Allergy Therapeutics’ VLP Peanut Shows Strong Immune Response in Early-Stage Trial
PremiumCompany AnnouncementsAllergy Therapeutics’ VLP Peanut Shows Strong Immune Response in Early-Stage Trial
4M ago
Allergy Therapeutics showcases new allergy immunotherapy data at AAAAI 2026
Premium
Company Announcements
Allergy Therapeutics showcases new allergy immunotherapy data at AAAAI 2026
4M ago
Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
Premium
Company Announcements
Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
4M ago
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
PremiumCompany Announcements
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
5M ago
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany Announcements
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
5M ago
Allergy Therapeutics Grants Performance-Linked Share Options to Senior Management
PremiumCompany Announcements
Allergy Therapeutics Grants Performance-Linked Share Options to Senior Management
5M ago
Allergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates
PremiumCompany Announcements
Allergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates
5M ago
Allergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing
PremiumCompany AnnouncementsAllergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing
6M ago
Allergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing
Premium
Company Announcements
Allergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing
6M ago
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
Premium
Company Announcements
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
7M ago
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
PremiumCompany Announcements
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
7M ago
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
PremiumCompany Announcements
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
7M ago
Allergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives
PremiumCompany Announcements
Allergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives
7M ago
Allergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial
PremiumCompany Announcements
Allergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial
7M ago
Allergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence
PremiumCompany AnnouncementsAllergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence
8M ago
Allergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment
Premium
Company Announcements
Allergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment
8M ago
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
Premium
Company Announcements
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >